Protocol No.: COG-ANBL1531

Title
Testing the Addition of 131I-MIBG or Crizotinib to Intensive Therapy in People With High-risk Neuroblastoma (NBL)
Principal Investigator
Paul, Stephan
Phase
III
Age Group
Both
Applicable Disease Site
Other Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contacts
Jan Rapp
Clinical Trials Manager
Phone: +1 304-293-1229
Carla Corbin, RN, BSN
Nurse Clinician
Phone: +1 304-293-1217
April Shay, MSN, PNP-BC
Nurse Practitioner
Phone: +1 304-293-1217
Denise Casino
Clinical Trials Manager
Phone: +1 304-293-0735

View on ClinicalTrials.gov